Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 11

Publication Record

Connections

Consensus on biomarkers for neuroendocrine tumour disease.
Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, Metz DC, Heaney A, Kwekkeboom D, Strosberg J, Meyer T, Moss SF, Washington K, Wolin E, Liu E, Goldenring J
(2015) Lancet Oncol 16: e435-e446
MeSH Terms: Biomarkers, Tumor, Delphi Technique, Humans, MicroRNAs, National Cancer Institute (U.S.), Neoplastic Cells, Circulating, Neuroendocrine Tumors, Prognosis, United States
Added April 12, 2016
0 Communities
1 Members
0 Resources
9 MeSH Terms
Genomic Classification of Cutaneous Melanoma.
Cancer Genome Atlas Network
(2015) Cell 161: 1681-96
MeSH Terms: Databases, Genetic, Humans, Melanoma, Mutation, National Cancer Institute (U.S.), Skin Neoplasms, United States
Added August 8, 2016
0 Communities
1 Members
0 Resources
7 MeSH Terms
Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.
Mountz JM, Yankeelov TE, Rubin DL, Buatti JM, Erikson BJ, Fennessy FM, Gillies RJ, Huang W, Jacobs MA, Kinahan PE, Laymon CM, Linden HM, Mankoff DA, Schwartz LH, Shim H, Wahl RL
(2014) J Clin Oncol 32: 2115-6
MeSH Terms: Antineoplastic Agents, Clinical Trials as Topic, Diagnostic Imaging, Disease Progression, Humans, Inflammation, National Cancer Institute (U.S.), Neoplasms, Predictive Value of Tests, Research Support as Topic, Treatment Outcome, United States
Added February 12, 2015
0 Communities
1 Members
0 Resources
12 MeSH Terms
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, Dilts DM, Duff ME, Ford JG, Joffe S, Schapira L, Weinfurt KP, Michaels M, Raghavan D, Richmond ES, Zon R, Albrecht TL, Bookman MA, Dowlati A, Enos RA, Fouad MN, Good M, Hicks WJ, Loehrer PJ, Lyss AP, Wolff SN, Wujcik DM, Meropol NJ
(2013) J Oncol Pract 9: 267-76
MeSH Terms: Attitude of Health Personnel, Clinical Trials as Topic, Humans, Leadership, Medical Oncology, National Cancer Institute (U.S.), Neoplasms, Patient Education as Topic, Patient Selection, Practice Patterns, Physicians', Societies, Medical, United States
Added March 7, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms
Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.
Ellis MJ, Gillette M, Carr SA, Paulovich AG, Smith RD, Rodland KK, Townsend RR, Kinsinger C, Mesri M, Rodriguez H, Liebler DC, Clinical Proteomic Tumor Analysis Consortium (CPTAC)
(2013) Cancer Discov 3: 1108-12
MeSH Terms: Biomarkers, Tumor, Breast Neoplasms, Colonic Neoplasms, Computational Biology, Female, Genome, Human, Genomics, Genotype, Humans, Molecular Sequence Annotation, Mutation, National Cancer Institute (U.S.), National Human Genome Research Institute (U.S.), Neoplasms, Ovarian Neoplasms, Phenotype, Proteomics, United States
Added March 20, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Operationalization of community-based participatory research principles: assessment of the national cancer institute's community network programs.
Braun KL, Nguyen TT, Tanjasiri SP, Campbell J, Heiney SP, Brandt HM, Smith SA, Blumenthal DS, Hargreaves M, Coe K, Ma GX, Kenerson D, Patel K, Tsark J, HĂ©bert JR
(2012) Am J Public Health 102: 1195-203
MeSH Terms: Community Networks, Community-Based Participatory Research, Community-Institutional Relations, Guideline Adherence, Humans, National Cancer Institute (U.S.), Research Design, Surveys and Questionnaires, United States
Added March 27, 2014
0 Communities
1 Members
0 Resources
9 MeSH Terms
How confident are young adult cancer survivors in managing their survivorship care? A report from the LIVESTRONG™ Survivorship Center of Excellence Network.
Casillas J, Syrjala KL, Ganz PA, Hammond E, Marcus AC, Moss KM, Crespi CM, Lu P, McCabe MS, Ford JS, Jacobs LA, Pucci D, Palmer SC, Termuhlen AM, Diller L, Campbell M, Jones B, Friedman DL
(2011) J Cancer Surviv 5: 371-81
MeSH Terms: Adolescent, Adult, Delivery of Health Care, Female, Humans, Male, National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division, National Cancer Institute (U.S.), Neoplasms, Patient Care Planning, Socioeconomic Factors, Survival Rate, Survivors, United States, Young Adult
Added March 27, 2014
0 Communities
1 Members
0 Resources
15 MeSH Terms
Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource.
Wujcik D, Wolff SN
(2010) J Health Care Poor Underserved 21: 38-50
MeSH Terms: African Americans, Clinical Trials as Topic, Hospitals, General, Humans, Interinstitutional Relations, National Cancer Institute (U.S.), Neoplasms, Patient Selection, Schools, Medical, Tennessee, United States
Added March 27, 2014
0 Communities
1 Members
0 Resources
11 MeSH Terms
Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.
Rodriguez H, Tezak Z, Mesri M, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Philip R, Ransohoff DF, Skates SJ, Regnier FE, Anderson NL, Mansfield E, Workshop Participants
(2010) Clin Chem 56: 237-43
MeSH Terms: Biomarkers, Tumor, Humans, Mass Spectrometry, National Cancer Institute (U.S.), Neoplasms, Proteomics, United States, United States Food and Drug Administration, Validation Studies as Topic
Added March 20, 2014
0 Communities
1 Members
0 Resources
9 MeSH Terms
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J
(2009) J Clin Oncol 27: 5660-9
MeSH Terms: Animals, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Pancreatic Ductal, Clinical Trials, Phase III as Topic, Combined Modality Therapy, Disease Models, Animal, Disease-Free Survival, Drug Delivery Systems, Female, Humans, Male, Mice, National Cancer Institute (U.S.), Neoplasm Invasiveness, Neoplasm Staging, Pancreatectomy, Pancreatic Neoplasms, Practice Guidelines as Topic, Prognosis, Risk Assessment, Survival Analysis, United States
Added March 20, 2014
0 Communities
1 Members
0 Resources
22 MeSH Terms